- Home
- BRC vs CPRX Comparison
BRC vs CPRX Comparison
Compare BRC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRC
- CPRX
- Stock Information
- Founded
- BRC 1914
- CPRX 2002
- Country
- BRC United States
- CPRX United States
- Employees
- BRC N/A
- CPRX N/A
- Industry
- BRC Miscellaneous manufacturing industries
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BRC Consumer Discretionary
- CPRX Health Care
- Exchange
- BRC Nasdaq
- CPRX Nasdaq
- Market Cap
- BRC 3.4B
- CPRX 2.9B
- IPO Year
- BRC 1984
- CPRX 2006
- Fundamental
- Price
- BRC $69.89
- CPRX $24.86
- Analyst Decision
- BRC
- CPRX Strong Buy
- Analyst Count
- BRC 0
- CPRX 7
- Target Price
- BRC N/A
- CPRX $32.29
- AVG Volume (30 Days)
- BRC 198.9K
- CPRX 1.1M
- Earning Date
- BRC 05-16-2025
- CPRX 05-07-2025
- Dividend Yield
- BRC 1.38%
- CPRX N/A
- EPS Growth
- BRC 3.35
- CPRX 178.13
- EPS
- BRC 4.03
- CPRX 1.57
- Revenue
- BRC $1,459,732,000.00
- CPRX $534,645,999.00
- Revenue This Year
- BRC $13.46
- CPRX $16.37
- Revenue Next Year
- BRC $4.07
- CPRX $8.80
- P/E Ratio
- BRC $17.31
- CPRX $15.91
- Revenue Growth
- BRC 8.62
- CPRX 29.97
- 52 Week Low
- BRC $62.70
- CPRX $14.75
- 52 Week High
- BRC $77.68
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- BRC 44.56
- CPRX 61.03
- Support Level
- BRC $69.26
- CPRX $24.19
- Resistance Level
- BRC $71.28
- CPRX $25.00
- Average True Range (ATR)
- BRC 1.55
- CPRX 0.68
- MACD
- BRC -0.40
- CPRX 0.07
- Stochastic Oscillator
- BRC 12.41
- CPRX 90.18
About BRC Brady Corporation
Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).